139
Views
8
CrossRef citations to date
0
Altmetric
Articles

The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nationwide analysis

ORCID Icon, , ORCID Icon, , &
Pages 358-363 | Received 09 May 2018, Accepted 06 Oct 2018, Published online: 09 Jan 2019

References

  • Zietman AL, Shipley WU, Kaufman DS. Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy. Ann Med. 2000; 32:34–42.
  • Witjes JA, Compérat E, Cowan NC, et al. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines. Eur Urol. 2014; 65:778–792.
  • Wunderlich H, Wolf M, Reichelt O, et al. Radical cystectomy with ultrasound-guided partial prostatectomy for bladder cancer: a complication-preventing concept. Urology 2006; 68:554–559.
  • Kotb A, Aprikian AG. Is sparing the prostate still considered radical cystectomy? The case against prostate-sparing cystectomy for bladder cancer. Cuaj. 2013;3:220–222.
  • Ruffion A, Manel A, Massoud W, et al. Preservation of prostate during radical cystectomy: Evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 2005; 65:703–707.
  • Damiano R, Di Lorenzo G, Cantiello F, et al. Clinicopathologic Features of Prostate Adenocarcinoma Incidentally Discovered at the Time of Radical Cystectomy: An Evidence-Based Analysis. Eur Urol. 2007; 52:648–657.
  • Wetterauer C, Weibel M, Gsponer JR, et al. Incidental prostate cancer prevalence at radical cystoprostatectomy-importance of the histopathological work-up. Virchows Arch. 2014; 465:629–636.
  • Pignot G, Salomon L, Neuzillet Y, et al. Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study. Ann Surg Oncol. 2014; 21:684–690.
  • Buse S, Höfner T, Müller SC, et al. Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy. Int J Urol. 2013; 20:866–871.
  • Scott R, Jr., Mutchnik DL, Laskowski TZ, et al. Carcinoma of the prostate in elderly men: incidence, growth characteristics and clinical significance. J Urol.1969;101:602–607.:
  • Thomas C, Giesswein A, Hainz M, et al. Concomitant Gleason Score ≥7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy. Int Urol Nephrol. 2015; 47:1789–1796.
  • Delongchamps NB, Mao K, Theng H, et al. Outcome of Patients with Fortuitous Prostate Cancer after Radical Cystoprostatectomy for Bladder Cancer. Eur Urol. 2005; 48:946–950.
  • Helgstrand JT, Klemann N, Roder MA, et al. Danish Prostate Cancer Registry - methodology and early results from a novel national database. Clin Epidemiol. 2016; 8:351–360.
  • Autorino R, Di Lorenzo G, Damiano R, et al. Pathology of the prostate in radical cystectomy specimens: A critical review. Surg Oncol. 2009; 18:73–84.
  • Mazzucchelli R, Barbisan F, Scarpelli M, et al. Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?. Am J Clin Pathol. 2009;131:279–283. :
  • Kurokawa K, Ito K, Yamamoto T, et al. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer. Urology 2004;63:268–272.
  • Soos G, Tsakiris I, Szanto J, et al. The Prevalence of Prostate Carcinoma and Its Precursor in Hungary: An Autopsy Study. Eur Urol. 2005; 48:739–744.
  • Crawford ED. Epidemiology of prostate cancer. Urology 2003; 62:3–12.
  • Pignot G, Salomon L, Lebacle C, et al. Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre study. BJU Int. 2015; 115:87–93.
  • Winkler MH, Livni N, Mannion EM, et al. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int. 2007; 99:554–558.
  • Singh A, Kinoshita Y, Rovito PM, Jr, et al. Higher than expected association of clinical prostate and bladder cancers. J Urol. 2005;173:1526–1529. :
  • Chun TY. Coincidence of Bladder and Prostate Cancer. J Urol. 1997; 157:65–67.
  • Gakis G, Stenzl A, Renninger M. Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy?. Scand J Urol. 2013;47:358–362.
  • Madersbacher S, Hochreiter W, Burkhard F, et al. Radical Cystectomy for Bladder Cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003; 21:690–696.
  • May M, Helke C, Nitzke T, et al. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. Urol Int. 2004; 72:103–111.
  • Manoharan M, Ayyathurai R, Soloway MS. Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome. BJU Int. 2009; 104:1227–1232.
  • Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World J Urol 2007; 25:285–295.
  • Pritchett TR, Moreno J, Warner NE, et al. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol. 1988; 139:1214–1216.
  • Bruins HM, Djaladat H, Ahmadi H, et al. Incidental Prostate Cancer in Patients with Bladder Urothelial Carcinoma: Comprehensive Analysis of 1,476 Radical Cystoprostatectomy Specimens. J Urol. 2013; 190:1704–1709.
  • Moschini M, Shariat SF, Freschi M, et al. Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer. Urol Int. 2017; 98:290–297.
  • Gakis G, Rink M, Fritsche HM, et al. Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer. Urol Int. 2016; 97:42–48.
  • Fahmy O, Khairul-Asri MG, Schubert T, et al. Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients. J Urol. 2017; 197:385–390.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.